Increased serum concentrations of signal peptide-Cub-Egf domain-containing protein-1 in patients with aneurysmal subarachnoid hemorrhage.

Clin Chim Acta

Department of Neurosurgery, Taizhou People's Hospital, Nantong University, 210 Yingchun Road, Taizhou, Jiangsu Province 225300, China.

Published: August 2016

AI Article Synopsis

  • SCUBE1 is a protein that serves as a marker for coagulation and is linked to the prognosis of critical illnesses, specifically in patients with aneurysmal subarachnoid hemorrhage (aSAH).
  • Researchers analyzed serum SCUBE1 levels in 125 aSAH patients compared to 125 controls, finding significantly higher levels in patients along with strong correlations to established clinical scoring systems.
  • The study concludes that elevated SCUBE1 levels could be a valuable predictor of poor outcomes in aSAH patients, potentially helping to identify those at greater risk of mortality or unfavorable recovery.

Article Abstract

Background: Signal peptide-Cub-Epidermal growth factor domain-containing protein 1 (SCUBE1), a marker for coagulation, is correlated with prognosis of some critical illnesses. The current study was designed to investigate the potential prognostic value of serum SCUBE1 concentrations in patients with aneurysmal subarachnoid hemorrhage (aSAH).

Methods: Serum SCUBE1 concentrations of 125 patients and 125 controls were determined. Multivariate analyses were performed to identify independent risk factors for 6-month mortality, overall survival and unfavorable outcome (Glasgow Outcome Scale score of 1-3).

Results: Serum SCUBE1 concentrations were significantly higher in patients than in controls (17.7±7. vs. 1.2±0.4ng/ml, P<0.001) and were associated highly with World Federation of Neurological Surgeons (WFNS) scores (t=5.109, P<0.001) and modified Fisher scores (t=4.329, P<0.001). SCUBE1 emerged as an independent predictor for 6-month clinical outcomes. It had similar area under receiver operating characteristic curve (AUC) to WFNS scores and modified Fisher scores. Moreover, it could markedly improve the AUC of WFNS scores and modified Fisher scores to predict 6-month unfavorable outcome.

Conclusion: Enhanced SCUBE1 concentrations are correlated with increasing severity and poor outcomes of aSAH patients, indicating SCUBE1 might have the potential to identify aSAH patients at risk of poor prognosis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2016.06.002DOI Listing

Publication Analysis

Top Keywords

serum scube1
12
scube1 concentrations
12
patients aneurysmal
8
aneurysmal subarachnoid
8
subarachnoid hemorrhage
8
increased serum
4
concentrations
4
serum concentrations
4
concentrations signal
4
signal peptide-cub-egf
4

Similar Publications

Development of industry in the modern world, the number of individuals working in noisy environments is increasing with each passing day. Noise causes an increase in the incidence of cardioembolic events, yet the relevant underlying pathophysiology remains unclear. In this study, we aimed to investigate the relationship between signal peptide and complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor domain-containing protein-1 (SCUBE-1) in the pathophysiology of cardioembolic events in individuals exposed to noisy environments.

View Article and Find Full Text PDF

Maternal Serum SCUBE-1: A Novel Ischemic Marker in Preeclampsia.

J Pers Med

November 2024

Department of Obstetrics and Gynecology, Faculty of Medicine, Karadeniz Technical University, 61080 Trabzon, Turkey.

Article Synopsis
  • SCUBE-1 is a new marker indicating ischemia and has been studied for its connection to uteroplacental blood flow in preeclampsia patients.
  • In the study, 32 preeclamptic women showed significantly higher maternal serum SCUBE-1 levels compared to a control group of 32 healthy pregnancies, alongside elevated uterine artery pulsatility indexes.
  • Although SCUBE-1 levels were higher in preeclampsia, there was no significant correlation with umbilical artery pulsatility index or cerebroplacental ratio, but a notable correlation was found with uterine artery pulsatility index.
View Article and Find Full Text PDF
Article Synopsis
  • Ovarian torsion (OT) is a rare but critical gynecological emergency that requires quick diagnosis and management, leading researchers to explore non-invasive biomarkers for detection.
  • A systematic review of literature from five databases examined studies on biomarkers related to OT, resulting in the inclusion of 23 articles that reported on both animal and human research.
  • Key biomarkers identified included ischemia-modified albumin (IMA), serum D-dimer (s-DD), and interleukin-6 (IL-6), with specificities reaching 93.3% and sensitivities ranging from 16.4% to 92.3%, indicating their potential for early identification of OT in patients.
View Article and Find Full Text PDF

Background: Acute mesenteric ischaemia (AMI) is a life-threatening disease where early diagnosis is critical to avoid morbidity and mortality from extensive irreversible bowel necrosis. Appropriate prediction of presence of bowel necrosis is currently not available but would help to choose the optimal method of treatment. The study aims to identify combinations of biomarkers that can reliably identify AMI and distinguish between potentially reversible and irreversible bowel ischaemia.

View Article and Find Full Text PDF

Objective: The aim of the study was to evaluate the protective effects of alpha-lipoic acid (ALA) on the liver, oxidative parameters, and signal peptide-CUB-epidermal growth factor-like domain-containing proteins 1 and 2 (SCUBE-1 and -2) in an experimental cholestatic hepatic ischemia-reperfusion (IR) model.

Materials And Methods: Twenty-four female rats were included in the study and divided into four groups of six rats each. Group 1 was the control group, in which only laparotomy was performed; Group 2 underwent laparotomy and received alpha-lipoic acid (ALA) on a daily basis; bile duct ligation was performed in Group 3; bile duct ligation was performed, and ALA was administered to Group 4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!